<DOC>
	<DOC>NCT02305043</DOC>
	<brief_summary>The aim of this study is to identify biomarkers predicting response or resistance factors of a targeted therapy with trastuzumab in advanced gastric cancer.</brief_summary>
	<brief_title>Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>histologically proven adenocarcinoma of the stomach or gastroesophageal junction stage IV patient receives chemotherapy signed informed consent Age &gt; 18 years Patient can not understand meaning and purpose of the study patient already received a chemotherapy treatment for advanced disease.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>non-interventional</keyword>
	<keyword>advanced gastric cancer</keyword>
	<keyword>Trastuzumab</keyword>
	<keyword>HER2</keyword>
</DOC>